BioCentury
ARTICLE | Financial News

China Resources planning China pharma fund

October 27, 2017 7:04 PM UTC

The China Resources Pharmaceutical Equity Investment Fund Management (Shantou) Company Ltd. subsidiary of drug distribution company China Resources Pharmaceutical Group Ltd. (HKSE:3320) proposed to raise RMB2,500 million ($376.8 million) in its China Resources Pharmaceutical Industrial Investment Fund LLP. The five-year fund will make equity investments in Chinese pharmaceutical companies...